e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
New aspects of cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
J. Bradley, S. Blume, M. Balp, S. Elborn (Newtownabbey, United Kingdom; Wisconsin, United States Of America; Basel, Switzerland)
Source:
Annual Congress 2010 - New aspects of cystic fibrosis
Session:
New aspects of cystic fibrosis
Session type:
Thematic Poster Session
Number:
4801
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Bradley, S. Blume, M. Balp, S. Elborn (Newtownabbey, United Kingdom; Wisconsin, United States Of America; Basel, Switzerland). Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK. Eur Respir J 2010; 36: Suppl. 54, 4801
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.
Source: International Congress 2019 – Clinical problems
Year: 2019
Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006
Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009
Thoracic excursions as an effect parameter for in hospital treatment of pulmonary exacerbations in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004
Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018
Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations
Source: Eur Respir J , 49 (4) 1601102; DOI: 10.1183/13993003.01102-2016
Year: 2017
Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept